Farms.com Home   Ag Industry News

We Haven’t Seen The End Of GMO Labelling Campaign

Failed California ‘Right to Know’ Campaign Says It Will Be Back In 2014

By , Farms.com

The California ‘Right to Know’ campaign, which was unsuccessful in its ballot initiative (Prob. 37) for labelling genetically engineered foods in November 2012, says that they will be back in 2014.

The campaign sent out an email to its supporters saying that they believe that their initiative failed because their opponents were able to raise more funds against their campaign, by a margin of 6-to-1.

In addition to outlining their intentions to come back in 2014, the steering committee also said that it will be heavily involved in Washington State’s new GMO proposal, along as having a watchful eye in other state legislative proposals.

Other state legislatures which have similar bills as the failed California initiative include New Mexico and Missouri. It’s also expected that Vermont and Connecticut will have similar bills introduced in the near future.

The California (Prob. 37) vote failed, but managed to secure 48.6% of the vote


Trending Video

Secure Pork Supply Plan | Prepare to Protect Your Herd | U.S. Pork Producers

Video: Secure Pork Supply Plan | Prepare to Protect Your Herd | U.S. Pork Producers

Join Jill Brokaw, a third-generation pig farmer, as she dives into the vital role of the Secure Pork Supply (SPS) Plan in preparing the U.S. pork industry for potential foreign animal disease outbreaks. This video is an essential watch for pork producers who are looking to safeguard their operations against the threats of diseases like foot and mouth disease, classical swine fever, and African swine fever. Why Should Pork Producers Care? An outbreak of foreign animal diseases in the U.S. could lead to severe restrictions and potentially result in industry-wide financial losses estimated between $15 to $100 billion. The SPS Plan is a collective effort to prevent such catastrophic outcomes by enhancing biosecurity, ensuring animal traceability, and promoting effective disease monitoring.